Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 9 of 15
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
NCT02186704
Mental Health Intervention for Elderly Abuse Victims
NCT02283385
Measuring Active Microglia in Progressive Multiple Sclerosis
NCT02207075
Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
NCT02341326
Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders
NCT02572973
Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma
NCT02059239
Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer
NCT01982149
RFA RCT for Pancreatic or Bile Duct Cancer
NCT02166190
Depression Decision Aid: Feasibility Pilot
NCT02239367
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
NCT02173275
Small RNA Pathways in Mammalian Gametogenesis
NCT02864329
Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome
NCT02067819
Dual Energy CT for Ischemia Determination Compared to "Gold Standard" Non-Invasive and Invasive Techniques
NCT02178904
Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
NCT02030483
HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
NCT02056158
Effects of Electronic Cigarettes on Lung Biology
NCT02188511
HIV-related Accelerated Aging of the Airway Epithelium
NCT01974219
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
NCT01974180
Back on My Feet: Emotional Recovery From Fall Injury
NCT01998945
COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function
NCT01974154
Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
NCT01757197
Peer to Peer Delivery of Behavioral Activation
NCT02292849
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
NCT02114905
Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
NCT01979276
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
NCT01980056
Attention Bias Modification Treatment for Anxious Youth
NCT01979263
Testing Whether Brief Use of a Virtual Reality Device Improves Gait
NCT01936922
Electrocardiography Data Analysis in Sleep Disorders
NCT02188498
Low Field Magnetic Stimulation for Treatment Resistant Depression
NCT01944644
Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
NCT01880086
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
NCT01998139
Ramipril for the Treatment of Oligospermia
NCT01856361
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery
NCT01783236
Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment
NCT01939938
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
NCT01884740
Endoluminal and Needlescopic Assisted Repair of Rectal Prolapse
NCT01980043
Adapting DBT for Children With DMDD: Pilot RCT
NCT01862549
Predicting Oxycodone Dose From Oral Fluid Drug Levels
NCT01928303
Alternate Nicotine Delivery Systems and Airway Epithelial Biology
NCT01974063
A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
NCT01799278
Safety and Efficacy of Eltrombopag at Escalated Doses
NCT01880047
Effect of CES on Parasympathetic Tone
NCT02163967
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
NCT01758588
Study of Dual Trigger Ovulation in Oocyte Donors
NCT01443546
3 Dimensional Sonography Imaging
NCT01872559
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
NCT01757171
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
NCT03393611
Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
NCT01734161
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
NCT01745913
Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk
NCT01923701
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.